TipRanks
Newron Pharmaceuticals SpA (DE:NP5)
XETRA:NP5
Germany Market
NP5
Newron Pharmaceuticals SpA
RESEARCH TOOLSreports

Newron Pharmaceuticals SpA (NP5) Balance Sheet

3 Followers

Newron Pharmaceuticals SpA Balance Sheet

Newron Pharmaceuticals SpA's total assets for Q2 2026 were €40.42M, an increase of 0.98% from the previous quarter. DE:NP5 total liabilities were €52.13M for the fiscal quarter, a 1.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
€ 40.02M€ 63.91M€ 25.87M€ 37.20M€ 50.49M
Total Liabilities
€ 51.15M€ 62.45M€ 55.77M€ 51.23M€ 47.38M
Total Equity Gross Minority
€ -11.13M€ 1.46M€ -29.91M€ -14.03M€ 3.11M
Other Metrics
Currency in EUR

Newron Pharmaceuticals SpA Debt to Assets